Medtronic Quick Ratio 2012-2026 | MDT
Historical quick ratio values for Medtronic (MDT) over the last 10 years.
| Medtronic Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2026-07-31 | $18.18B | $11.80B | 1.54 |
| 2026-04-30 | $18.84B | $11.66B | 1.62 |
| 2026-01-31 | $17.76B | $9.50B | 1.87 |
| 2025-10-31 | $17.84B | $9.94B | 1.80 |
| 2025-07-31 | $17.34B | $11.53B | 1.50 |
| 2025-04-30 | $18.34B | $12.88B | 1.42 |
| 2025-01-31 | $16.90B | $11.84B | 1.43 |
| 2024-10-31 | $16.96B | $12.20B | 1.39 |
| 2024-07-31 | $16.53B | $10.29B | 1.61 |
| 2024-04-30 | $16.72B | $10.79B | 1.55 |
| 2024-01-31 | $16.79B | $9.79B | 1.71 |
| 2023-10-31 | $16.33B | $9.66B | 1.69 |
| 2023-07-31 | $16.20B | $9.05B | 1.79 |
| 2023-04-30 | $16.38B | $9.05B | 1.81 |
| 2023-01-31 | $19.99B | $14.42B | 1.39 |
| 2022-10-31 | $20.34B | $14.47B | 1.41 |
| 2022-07-31 | $17.33B | $14.05B | 1.23 |
| 2022-04-30 | $18.44B | $12.39B | 1.49 |
| 2022-01-31 | $18.79B | $8.93B | 2.11 |
| 2021-10-31 | $18.38B | $7.80B | 2.36 |
| 2021-07-31 | $18.15B | $7.76B | 2.34 |
| 2021-04-30 | $18.24B | $8.51B | 2.14 |
| 2021-01-31 | $21.84B | $12.53B | 1.74 |
| 2020-10-31 | $21.55B | $12.07B | 1.79 |
| 2020-07-31 | $19.96B | $13.09B | 1.53 |
| 2020-04-30 | $17.80B | $10.37B | 1.72 |
| 2020-01-31 | $19.92B | $8.74B | 2.28 |
| 2019-10-31 | $18.61B | $8.17B | 2.28 |
| 2019-07-31 | $18.77B | $8.52B | 2.20 |
| 2019-04-30 | $18.21B | $8.47B | 2.15 |
| 2019-01-31 | $17.01B | $8.85B | 1.92 |
| 2018-10-31 | $17.89B | $8.46B | 2.11 |
| 2018-07-31 | $18.78B | $9.11B | 2.06 |
| 2018-04-30 | $19.40B | $10.08B | 1.92 |
| 2018-01-31 | $22.86B | $10.93B | 2.09 |
| 2017-10-31 | $21.52B | $10.50B | 2.05 |
| 2017-07-31 | $21.24B | $15.15B | 1.40 |
| 2017-04-30 | $21.54B | $14.26B | 1.51 |
| 2017-01-31 | $18.70B | $12.67B | 1.48 |
| 2016-10-31 | $18.81B | $9.60B | 1.96 |
| 2016-07-31 | $19.92B | $7.90B | 2.52 |
| 2016-04-30 | $20.13B | $7.17B | 2.81 |
| 2016-01-31 | $24.03B | $8.14B | 2.95 |
| 2015-10-31 | $25.21B | $8.13B | 3.10 |
| 2015-07-31 | $25.74B | $7.66B | 3.36 |
| 2015-04-30 | $27.38B | $9.17B | 2.99 |
| 2015-01-31 | $36.29B | $5.61B | 6.47 |
| 2014-10-31 | $19.72B | $6.95B | 2.84 |
| 2014-07-31 | $18.93B | $5.43B | 3.49 |
| 2014-04-30 | $19.49B | $5.56B | 3.51 |
| 2014-01-31 | $18.60B | $5.63B | 3.30 |
| 2013-10-31 | $17.66B | $5.50B | 3.21 |
| 2013-07-31 | $16.31B | $4.29B | 3.81 |
| 2013-04-30 | $16.14B | $3.95B | 4.09 |
| 2013-01-31 | $7.27B | $6.96B | 1.05 |
| 2012-10-31 | $7.56B | $6.62B | 1.14 |
| 2012-07-31 | $7.33B | $5.81B | 1.26 |
| 2012-04-30 | $14.54B | $5.93B | 2.45 |
| 2012-01-31 | $7.49B | $4.56B | 1.64 |
| 2011-10-31 | $7.17B | $4.73B | 1.52 |
| 2011-07-31 | $7.48B | $4.81B | 1.56 |
| 2011-04-30 | $7.53B | $4.73B | 1.59 |
| 2011-01-31 | $8.30B | $6.41B | 1.30 |
| 2010-10-31 | $8.26B | $5.90B | 1.40 |
| 2010-07-31 | $8.42B | $5.61B | 1.50 |
| 2010-04-30 | $8.36B | $5.12B | 1.63 |
| 2010-01-31 | $6.51B | $3.79B | 1.72 |
| 2009-10-31 | $5.84B | $3.28B | 1.78 |
| 2009-07-31 | $5.79B | $3.13B | 1.85 |
| 2009-04-30 | $6.03B | $3.15B | 1.92 |
| 2009-01-31 | $5.78B | $3.17B | 1.82 |
| 2008-10-31 | $5.15B | $2.91B | 1.77 |
| 2008-07-31 | $6.04B | $3.72B | 1.62 |
| 2008-04-30 | $6.04B | $3.54B | 1.71 |
| 2008-01-31 | $5.37B | $3.54B | 1.52 |
| 2007-10-31 | $9.29B | $2.65B | 3.51 |
| 2007-07-31 | $6.43B | $2.04B | 3.15 |
| 2007-04-30 | $6.70B | $2.56B | 2.62 |
| 2007-01-31 | $6.89B | $2.70B | 2.55 |
| 2006-10-31 | $7.11B | $2.70B | 2.64 |
| 2006-07-31 | $9.15B | $4.44B | 2.06 |
| 2006-04-30 | $9.20B | $4.41B | 2.09 |
| 2006-01-31 | $7.75B | $4.87B | 1.59 |
| 2005-10-31 | $6.99B | $4.90B | 1.43 |
| 2005-07-31 | $6.09B | $3.60B | 1.69 |
| 2005-04-30 | $6.44B | $3.38B | 1.91 |
| 2005-01-31 | $5.71B | $2.66B | 2.15 |
| 2004-10-31 | $5.39B | $2.49B | 2.17 |
| 2004-07-31 | $4.94B | $4.30B | 1.15 |
| 2004-04-30 | $4.44B | $4.24B | 1.05 |
| 2004-01-31 | $3.66B | $4.07B | 0.90 |
| 2003-10-31 | $3.42B | $3.95B | 0.87 |
| 2003-07-31 | $3.42B | $1.81B | 1.89 |
| 2003-04-30 | $3.75B | $1.90B | 1.98 |
| 2003-01-31 | $3.58B | $1.75B | 2.05 |
| 2002-10-31 | $3.30B | $1.70B | 1.94 |
| 2002-07-31 | $3.16B | $3.89B | 0.81 |
| 2002-04-30 | $2.74B | $3.99B | 0.69 |
| 2002-01-31 | $2.58B | $3.64B | 0.71 |
| 2001-10-31 | $2.37B | $3.56B | 0.66 |
| 2001-07-31 | $3.20B | $1.32B | 2.42 |
| 2001-04-30 | $3.03B | $1.36B | 2.23 |
| 2001-01-31 | $2.32B | $0.95B | 2.44 |
| 2000-10-31 | $2.46B | $1.02B | 2.41 |
| 2000-07-31 | $2.37B | $0.96B | 2.46 |
| 2000-04-30 | $2.35B | $0.99B | 2.36 |
| 2000-01-31 | $2.02B | $1.12B | 1.81 |
| 1999-10-31 | $1.84B | $1.10B | 1.67 |
| 1999-07-31 | $1.80B | $0.98B | 1.83 |
| 1999-04-30 | $1.84B | $0.99B | 1.86 |
| 1999-01-31 | $2.00B | $1.17B | 1.72 |
| 1998-10-31 | $1.85B | $0.77B | 2.39 |
| 1998-07-31 | $1.25B | $0.58B | 2.17 |
| 1998-04-30 | $1.22B | $0.57B | 2.13 |
| 1998-01-31 | $1.18B | $0.60B | 1.96 |
| 1997-10-31 | $1.06B | $0.50B | 2.12 |
| 1997-07-31 | $1.02B | $0.52B | 1.98 |
| 1997-04-30 | $0.96B | $0.52B | 1.84 |
| 1997-01-31 | $1.21B | $0.49B | 2.48 |
| 1996-10-31 | $1.18B | $0.47B | 2.51 |
| 1996-07-31 | $1.16B | $0.46B | 2.53 |
| 1996-04-30 | $1.09B | $0.53B | 2.07 |
| 1996-01-31 | $0.99B | $0.39B | 2.54 |
| 1995-10-31 | $0.97B | $0.39B | 2.48 |
| 1995-07-31 | $1.01B | $0.43B | 2.34 |
| 1995-04-30 | $0.88B | $0.46B | 1.93 |
| 1995-01-31 | $0.70B | $0.39B | 1.81 |
| 1994-10-31 | $0.66B | $0.40B | 1.67 |
| 1994-07-31 | $0.61B | $0.42B | 1.46 |
| 1994-04-30 | $0.63B | $0.44B | 1.44 |
| 1994-01-31 | $0.61B | $0.28B | 2.14 |
| 1993-10-31 | $0.52B | $0.25B | 2.07 |
| 1993-07-31 | $0.54B | $0.29B | 1.88 |
| 1993-04-30 | $0.59B | $0.35B | 1.67 |
| 1993-01-31 | $0.62B | $0.28B | 2.22 |
| 1992-10-31 | $0.59B | $0.27B | 2.17 |
| 1992-07-31 | $0.49B | $0.27B | 1.86 |
| 1992-04-30 | $0.52B | $0.31B | 1.69 |
| 1992-01-31 | $0.49B | $0.28B | 1.75 |
| 1991-10-31 | $0.47B | $0.27B | 1.74 |
| 1991-07-31 | $0.45B | $0.26B | 1.76 |
| 1991-04-30 | $0.47B | $0.29B | 1.62 |
| 1991-01-31 | $0.42B | $0.27B | 1.59 |
| 1990-10-31 | $0.42B | $0.28B | 1.47 |
| 1990-07-31 | $0.36B | $0.27B | 1.36 |
| 1990-04-30 | $0.37B | $0.26B | 1.41 |
| 1990-01-31 | $0.31B | $0.24B | 1.32 |
| 1989-10-31 | $0.31B | $0.23B | 1.36 |
| 1989-07-31 | $0.30B | $0.22B | 1.38 |
| 1989-04-30 | $0.30B | $0.23B | 1.30 |
| 1989-01-31 | $0.28B | $0.20B | 1.43 |
| 1988-10-31 | $0.27B | $0.19B | 1.40 |
| 1988-07-31 | $0.30B | $0.23B | 1.33 |
| 1988-04-30 | $0.31B | $0.19B | 1.66 |
| 1988-01-31 | $0.26B | $0.15B | 1.68 |
| 1987-10-31 | $0.27B | $0.14B | 1.85 |
| 1987-07-31 | $0.29B | $0.13B | 2.18 |
| 1987-04-30 | $0.28B | $0.13B | 2.24 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $119.983B | $36.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.651B | 13.13 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |